Mabl pricing in 2026: what is published and what is not.
Mabl does not publish per-seat or per-test pricing on its public site. Pricing is quoted as a custom enterprise contract scoped to the customer's test volume, parallelisation, environment count, and seat count. This page explains what is documented, what affects the total, and how to budget for the surrounding costs that are not on the vendor invoice.
The published surface
The Mabl vendor site (mabl.com) routes buyers to a contact form rather than a public pricing page with list prices. The published collateral describes a SaaS end-to-end testing platform with low-code authoring, self-healing locators, and CI integrations. There is no published per-seat or per-test rate as of April 2026. This is not unusual in the category; Testim, Functionize, QA Wolf, and most other self-healing platforms follow the same model.
The published model is therefore best read as "enterprise contract, terms by negotiation," with the vendor asking buyers to scope their needs in a discovery call before quoting. Buyers who want a pre-conversation budget number have to triangulate from secondary sources (G2 reviews, Vendr marketplace medians, RFP outcomes shared in private buyer communities) rather than from the vendor page itself.
What drives the quote
The variables that affect a Mabl quote, per the vendor's published scoping conversations and the broader self-healing-platform category norms:
Number of tests in scope. A team running 200 tests pays differently from a team running 5,000 tests. The vendor scopes both authoring and execution to the test count, with discount tiers as volume increases.
Parallelisation requirements. Running 50 tests sequentially over an hour costs differently from running 50 tests in parallel over a minute. The vendor manages the test infrastructure so high parallelism is priced as a resource consumption, not as customer-side compute.
Environment count. Teams that test against multiple environments (staging, production, customer-specific tenants) consume more configuration and test runs than teams targeting a single environment.
Seat count. Test authors and administrators are seated. View-only or results-consumer seats are typically lower-priced or included in higher tiers; this varies by contract.
Integration depth. Single-sign-on, audit logs, custom data residency, and dedicated support all sit in the higher contract tiers.
Hidden costs beyond the license
The line items that show up after the contract is signed and surprise teams that did not budget for them:
CI minutes. Mabl tests run in the Mabl cloud, but the trigger and result-consumption happens in CI. The CI runner that invokes Mabl and waits for results consumes CI minutes on whichever platform the team uses. See AI testing in GitHub Actions for the cost math; the same shape applies to GitLab CI, CircleCI, and Jenkins-on-paid-runners.
Integration engineering. The first month after signing typically requires 0.5 to 1.0 FTE of integration work: connecting the application, training the team on authoring, setting up the CI integration, and tuning the self-healing baseline. This is real engineering time that the contract does not cover.
Reviewer overhead. When a self-healing test passes despite the application changing in a way the team did not intend, the failure surfaces later than it would have with a brittle test. Teams need a reviewer cadence (often weekly) to scan self-healing changes and flag intentional regressions. Budget 0.1 to 0.3 FTE for this cadence on a 1,000-test suite.
SOC 2 and security review. For regulated buyers, the vendor-risk review process (collecting SOC 2 Type II reports, DPIA review, data residency confirmation) consumes legal and security team time. This is a procurement cost, not a vendor cost, but it is real and often understated.
Budgeting before a sales conversation
For teams that need a budget figure before talking to the vendor, the honest approach is to combine three signals: published medians on the Vendr marketplace for self-healing platforms in the team's size range; G2 review snippets that mention prices (a smaller signal but occasionally useful); and direct conversations with peer companies that have published their stack choices. The composite is a defensible range rather than a single number, and the actual quote may move within that range based on the customer's leverage.
What does not work: extrapolating from a single anecdote, treating a quote one company got two years ago as a current rate, or assuming list price exists when the vendor explicitly does not publish one. The category norm is custom and the quote-to-quote variance is meaningful.
How to make the procurement efficient
Buyers can shorten the sales cycle by walking into the discovery call with the variables scoped: how many tests, what parallelism, how many environments, how many seats, what compliance posture, what CI runner. The vendor's scoping conversation becomes a quote conversation rather than a discovery conversation. This typically cuts the time-to-quote in half and gets to a defensible procurement decision faster.
On the customer side, the procurement decision should compare Mabl against Testim for the most common pairing, against newer entrants like Meticulous or Momentic if the team is open to a different mechanism, and against a managed-service alternative like QA Wolf or testRigor if the team is open to a structurally different delivery model.
What to ask the vendor
Questions worth surfacing in the first scoping call: what is the included parallelism on the proposed tier; what is the per-test or per-run overage rate; what is the seat economics for view-only versus authoring seats; what is the contract term and what are the renewal-rate caps; what is the data-handling policy for screenshots and DOM captures that may contain PII; and what is the published SLO for the vendor cloud (latency to first result on a triggered run, uptime commitment).
Frequently asked questions
- Does Mabl have a free tier?
- Mabl offers a free trial rather than a perpetual free tier. The trial period and feature scope are documented on the vendor signup page and have changed over time; check the current trial terms at vendor signup rather than relying on a third-party summary.
- Is pricing per seat or per test?
- Public collateral describes pricing as scoped to test volume, parallelisation, and seat count rather than a single unit. The effective rate per test depends on the customer's mix of authenticated users, environments, and parallel runs, which is why custom contracts are the norm in this category.
- Are there hidden costs?
- Beyond the license, the costs that surprise teams include CI minutes for the runner that invokes Mabl, integration engineering time for the first month, and the reviewer time required when self-healing tests fail in non-obvious ways. None of these are vendor-charged but all are real budget lines.
- How does Mabl pricing compare to Testim?
- Both are custom enterprise contracts; neither publishes per-seat list prices. Effective pricing depends on negotiation, deal size, and any existing platform relationship (Testim's parent Tricentis may bundle; Mabl as an independent does not). See the Mabl vs Testim comparison for the structural framing.
- Can I export tests from Mabl if I cancel?
- Mabl tests live in the vendor platform format. Export to a portable format is possible per documentation but the canonical representation is the vendor's. Buyers should weigh portability as part of the procurement decision rather than discover it during an exit.
Related on this site